2011 - Transplantomics and Biomarkers in Transplantation


Long Term Outcomes (CR/Tol)

3.4 - Biomarkers of Operational Tolerance in Clinical Liver Transplantation

Presenter: Alberto, Sanchez-Fueyo, Barcelona, Spain
Authors: Alberto Sanchez-Fueyo


Biomarkers of Operational Tolerance in Clinical Liver Transplantation

Alberto Sanchez-Fueyo, University of Barcelona, Barcelona, Spain

A proportion of liver transplant recipients can spontaneously accept their grafts in the absence of immunosuppression (operational tolerance). Unfortunately, we lack accurate predictive markers to identify tolerant liver recipients before therapy is discontinued. Our work has been focused on the search of transcriptional and cell phenotypic biomarkers of tolerance in liver transplantation. Tolerant and non-tolerant liver recipients differ in their blood gene expression profiles. These differences are associated with an expansion of NK cells in the blood of tolerant recipients, and are already detectable before immunosuppressive drugs are discontinued. On the other hand, analysis of liver tissue samples obtained before drug withdrawal reveals that tolerant and non-tolerant grafts differ in an unexpectedly small number of genes, many of which are involved in the regulation of iron metabolism. These findings will likely provide useful diagnostic markers to screen patients for immunosuppression minimization strategies.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi